Cargando…

Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

Hodgkin's lymphoma represents one of the most frequent lymphoproliferative syndromes, especially in young population. Although HL is considered one of the most curable tumors, a sizeable fraction of patients recur after successful upfront treatment or, less commonly, are primarily resistant. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Cruz-Merino, Luis, Lejeune, Marylène, Nogales Fernández, Esteban, Henao Carrasco, Fernando, Grueso López, Ana, Illescas Vacas, Ana, Pulla, Mariano Provencio, Callau, Cristina, Álvaro, Tomás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426211/ https://www.ncbi.nlm.nih.gov/pubmed/22927872 http://dx.doi.org/10.1155/2012/756353

Ejemplares similares

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
por: Rueda Domínguez, A., et al.
Publicado: (2015)

SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
por: Provencio Pulla, M., et al.
Publicado: (2015)

Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored
por: de la Cruz-Merino, Luis, et al.
Publicado: (2014)

Long-term follow up of Hodgkin lymphoma
por: Perez-Callejo, David, et al.
Publicado: (2018)

Several immune escape patterns in non-Hodgkin's lymphomas
por: Laurent, Camille, et al.
Publicado: (2015)

Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes
por: Álvaro, Tomás, et al.
Publicado: (2010)

A multistep image analysis method to increase automated identification efficiency in immunohistochemical nuclear markers with a high background level
por: Lejeune, Marylène, et al.
Publicado: (2013)

Acute liver failure as the first manifestation of very late relapsing of Hodgkin's disease
por: Ortín, Xavier, et al.
Publicado: (2010)

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma
por: Mata, Elena, et al.
Publicado: (2019)

Primary Extranodal, Extralymphatic Hodgkin Lymphoma of the Mandible
por: Gonzalez-Fontal, Guido Ricardo, et al.
Publicado: (2011)

Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining
por: Péricart, Sarah, et al.
Publicado: (2018)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group
por: Provencio, Mariano, et al.
Publicado: (2017)

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets
por: Mata, Elena, et al.
Publicado: (2017)

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
por: Palazón-Carrión, Natalia, et al.
Publicado: (2022)

Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma
por: Blanco, Mariola, et al.
Publicado: (2022)

Evaluation of cytokeratin-19 in breast cancer tissue samples: a comparison of automatic and manual evaluations of scanned tissue microarray cylinders
por: Callau, Cristina, et al.
Publicado: (2015)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Hodgkin Lymphoma in People Living with HIV
por: Navarro, Jose-Tomas, et al.
Publicado: (2021)

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Non-Hodgkin lymphoma with relapses in the lacrimal glands
por: Couceiro, Rita, et al.
Publicado: (2015)

Circulating tumor DNA in Hodgkin lymphoma
por: Maco, Maria, et al.
Publicado: (2022)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
por: Srivastava, Aayushi, et al.
Publicado: (2020)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
por: de la Cruz-Merino, Luis, et al.
Publicado: (2013)

Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis
por: Tsuyuki, Yuta, et al.
Publicado: (2021)

Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861
por: Panjideh, Hossein, et al.
Publicado: (2022)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

Non Hodgkin T cell lymphoma: an atypical clinical presentation
por: Maio, Paula, et al.
Publicado: (2013)

Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study
por: López, Carlos, et al.
Publicado: (2014)

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma
por: Tarekegn, Kidist, et al.
Publicado: (2021)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
por: Kiani, Hadis, et al.
Publicado: (2016)

Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma
por: Dias, Joana N. R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h6hvlko8hbfe5vopthjei2hvmm